SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
Phase 1 / Phase 2 · 1 site
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 1 site
Phase 2 · 1 site
Phase 3 · 79 sites
Phase 1 · 1 site
Phase 1 / Phase 2 · 15 sites
Potential match only. Final eligibility is determined by the study team.